Mitochondrial complex I (CI) is a multi-subunit enzyme that forms the major entry point of nicotinamide adenine dinucleotide (NADH) electrons into the respiratory chain. Mutations in the NDUFS4 gene, encoding an accessory subunit of this complex, cause a Leigh-like phenotype in humans. To study the nature and penetrance of the CI defect in different tissues, we investigated the role of NDUFS4 in mice with fatal mitochondrial encephalomyopathy, caused by a systemic inactivation of the Ndufs4 gene. We report that the absence of NDUFS4 in different mouse tissues results in decreased activity and stability of CI. This CI instability leads to an increased disconnection of electron influx of the NADH dehydrogenase module from the holo-complex. However, the formation of respiratory supercomplexes still allows formation of active CI in these Ndufs4 knock-out mice. These results reveal the importance of these supramolecular interactions not only for stabilization but also for the assembly of CI, which becomes especially relevant in pathological conditions.
INTRODUCTION
Mitochondrial complex I (CI) deficiency is the most widespread enzyme defect in oxidative phosphorylation (OXPHOS), leading to a clinically heterogeneous class of metabolic disorders. The enzyme is a large multi-subunit complex, which serves as the electron influx part of the respiratory chain. The energy released from the transfer of two electrons from nicotinamide adenine dinucleotide (NADH) to ubiquinone is used to translocate four protons from the mitochondrial matrix to the inter-membrane space, contributing to build-up a proton gradient across the mitochondrial inner-membrane, which is utilized to generate ATP.
Mammalian CI is an L-shaped molecule embedded in the mitochondrial inner membrane with a size of 1 MDa. The complex is formed by 45 protein subunits and it is believed to be organized in three functional modules: (i) an NADH dehydrogenase part, which catalyzes electron influx by oxidizing NADH; (ii) a hydrogenase part, which conducts the electrons to ubiquinone, its final electron acceptor; and (iii) a membrane-bound part, which acts as a conformation-driven proton pump (1) . The assembly of CI is a multi-step process, in which several subunits are first combined into smaller intermediates of the three functional modules, and then these preassembled parts, with additional subunits, are joined to form the holo-enzyme. This process is aided by specific proteins, the so-called assembly chaperones (2) . In addition, different studies showed that CI is not independently dispersed in the mitochondrial membrane, but it forms together, with CIII and CIV, supramolecular structures called supercomplexes. The supercomplexes might serve to reduce the diffusion distance of the substrates, to improve electron transfer, to decrease the reactive oxygen species formation and to stabilize the individual complexes (3, 4) .
Previous studies have identified numerous disease-causing mutations in the intrinsic subunits (5) and more recently in the assembly chaperones (6) . These mutations give rise to large diversity of clinical presentations, including Leigh or Leigh-like syndrome, cardiomyopathy, leukodystrophy and hepatopathy. The molecular basis of this variety of disorders is still poorly understood. The NDUFS4 subunit is a small protein of 18 kDa (7), which is thought to be important in CI assembly and function. Mutational analyses of CI-deficient patients have revealed several loss-of-function mutations in the NDUFS4 gene (8) (9) (10) (11) . CI assembly studies of patient fibroblasts showed that the NDUFS4 subunit is inserted in the complex at late stage of assembly process (12) (13) (14) and that the absence of NDUFS4 leads to the formation of a partially assembled 830 kDa subcomplex and lack of fully assembled CI (9, 14, 15) . Despite this absence of fully assembled CI in blue native gels (BN -PAGE) in NDUFS4 patient samples, some CI activity could still be measured by spectrophotometric analysis (8 -11,16) . So far, no explanation could be given for this discrepancy between the BN -PAGE findings and the spectrophotometric assay.
Mice in which the Ndufs4 gene was disrupted develop a neurological phenotype similar to Leigh (like) syndrome patients with mutations in this gene (17, 18) . The symptoms included encephalomyopathy, growth retardation, lethargy, loss of motor skills, blindness and elevated serum lactate levels (18) . Remarkably, a mouse with a brain-specific disruption of this gene has a clinical phenotype which is basically identical to the systemic inactivation of the Ndufs4 gene (19) . This raises the question whether in the systemic Ndufs4 knock-out (KO) mice, disruption in the peripheral tissues is less detrimental for CI activity compared with the brain. We therefore investigated the biochemical and molecular defects in various tissues of the Ndufs4 KO mice. Our data show that the loss of NDUFS4 affects CI in all tissues, although there are differences in residual CI activities. We demonstrate that this CI defect is due to instability of the complex leading to the loss of the NADH dehydrogenase electron influx part from the enzyme. CI in NDUFS4-deficient mice is stabilized by the formation of the supercomplex that includes CIII.
RESULTS

CI activity is decreased but not abolished in the absence of NDUFS4 in different tissues
Inactivation of the CI-subunit gene Ndufs4 in mice leads to viable offspring which develop encephalomyopathy and die within 50 days after birth (18) . To investigate whether this neurological phenotype is due to tissue-specific CI defects, we measured the activity of CI and OXPHOS CII -CV in various tissues of wild-type (WT), heterozygous (Het) and KO mice (Table 1 ). All investigated tissues of the KO mice showed a significant decrease in CI activity compared with the control values. Nevertheless, there were remarkable differences in the residual activities in the different KO tissues. In heart tissue, there was a residual activity of 44% of the control values; whereas the muscle, brain and kidney had a residual activity of 29, 26 and 25%, respectively; while the pancreas, liver and lung showed residual activities of 17, 19 and 9%, respectively. No significant differences in CII -CV activities were found in the KO samples compared with the WT and Het (data not shown).
The absence of NDUFS4 affects CI assembly and/or stability To further investigate whether these differences in residual activities in the different KO tissues were due to variation in assembly or stability of CI we studied the OXPHOS complexes using blue native gel electrophoresis (BN -PAGE). Western blot analysis of BN -PAGE using complex-specific antibodies revealed that fully assembled CI was absent in all investigated tissues in the KO mice, in contrast to WT and Het mice (Fig. 1A) . CII -CV remained normal in all tissues of the KO and Het compared with the WT mice (Fig. 1A ). In the KO mouse tissues, a lower molecular weight CI subcomplex of 830 kDa was observed, resembling the subassembly also observed in NDUFS4 patient fibroblasts (9, 15, 20) . Note that the amount of this subassembly was markedly less in the KO tissues compared with the amount of fully assembled CI in the corresponding Het and WT tissues. This suggests that this large subassembly does not accumulate in similar amounts as CI itself.
In fibroblasts, the 830 kDa subassembly contained the CI-assembly protein NDUFAF2 (15) . To verify whether the mouse 830 kDa CI subassembly was also associated with this chaperone, we performed a two-dimensional blue native SDS-PAGE (2D BN/SDS -PAGE) from the kidney and brain. Western blots of these gels indicated a specific co-localization of NDUFAF2 with the 830 kDa mouse CI subcomplex in the KO mouse tissues, whereas it was absent in the Het tissues, which lack the 830 kDa subassembly (Fig. 1B) .
Ndufs4 KO mitochondria contain a loose NADH dehydrogenase module NADH oxidation of CI and CI subassemblies was measured by an in-gel activity assay (IGA) using the artificial electron acceptor nitrotetrazolium blue. WT and Het tissues displayed a single IGA-positive band at the height of fully assembled CI, whereas the corresponding KO tissues failed to show a positive signal at CI position or at 830 kDa subassembly ( Fig. 2A ). The latter result shows that the 830 kDa subassembly completely lacked IGA. Remarkably, in some of the KO mouse tissues (kidney, brain, heart and muscle), an additional low molecular weight band of 200 kDa was found (indicated by arrows in Fig. 2A ). Because this 200 kDa band gives NADH oxidation, we reasoned that it is likely the NADH dehydrogenase module. This module contains at least CI-subunits NDUFV1-3 and represents the NADH-binding part of the complex. To test this possibility, we incubated the BN -PAGE western blot with an antibody against NDUFV2, one of the subunits present in this part. The signal obtained with the NDUFV2 CI activities are normalized to CIV (mU C.I/U C.IV) and expressed as percentage of the WT mice + SD (n). Assays were performed in duplicated for each samples, P ¼ 0.001 by Student's t-test.
antibody corresponded exactly with the accumulation of the 200 kDa CI subassembly as observed in the IGA for KO mouse tissues (Fig. 2B) . Moreover, because of the high sensitivity of antibody detection the 200 kDa CI subassembly could also be observed in liver and lung.
NDUFS4 lacking but fully assembled CI is present in a supercomplex with CIII
To investigate how the disturbed CI assembly/stability affects the formation of respiratory supercomplexes in the NDUFS4 KO mice, we performed BN -PAGE using the detergent digitonin instead of n-dodecylmaltoside. This milder extraction condition allows loose interactions to remain intact. BN -PAGE gels were loaded with mitochondrial samples from muscle and further processed for IGA and western blot. In the WT and Het mitochondria, CI was present in the monomeric form and in various supercomplex forms, CI + CIII 2 and CI + CIII 2 + CIV 1 -4 (Fig. 3A) . Interestingly, IGA of complexes from the KO mouse showed NADH oxidation activity in CI + CIII 2 , but not in free CI (Fig. 3A indicated with CI). In the western blot analyses of KO samples, a double CI band at the supercomplex position was observed when we incubated with anti-NDUFA9 (Fig. 3A) . The upper band likely represents a CI-CIII 2 supercomplex, since this gives NADH oxidase activity (as showed in IGA, Fig. 3 ) and has a comparable molecular size as in WT and Het tissues (Fig. 3A) ; whereas the lower band likely represents a supercomplex containing CIII and the 830 kDa CI subcomplex (830 + CIII 2 ). The large supercomplexes (CI + CIII 2 + CIV 1 -4 ) were almost absent in the KO samples, possibly reflecting the decreased stability of these supercomplexes in the KO samples. Notably, a tiny band co-migrating with the 830 + CIII 2 complex was also observed in the WT and Het samples. This band reacts with both the CI (Fig. 3A) and CIII antibody (data not shown) and has no in-gel activity, suggesting that it represents indeed the 830 + CIII 2 supercomplex. No loose 830 kDa subassembly was observed in these samples. Moreover, only the 830 kDa CI subassembly, but not the intact free CI, was detected in the KO mouse samples.
To investigate whether the 830 + CIII 2 still contains assembly factor NDUFAF2, we incubated an additional supercomplex gel western blot using antibodies against the chaperone and CI subunit NDUFA9 (Fig. 3B) . We observed clear NDUFAF2 signals in the KO samples, which had similar intensities and co-localizes with the NDUFA9 bands representing the 830 kDa subassembly and the 830 + CIII 2 supercomplex. In addition, faint NDUFAF2 bands in the CI + CIII 2 supercomplex were visible in the WT and Het samples, which did not correspond with the intensity of this complex, as seen in the NDUFA9 blot. No NDUFAF2 signal was seen at the height of CI.
These data suggest that under mild extraction conditions, likely representing a more physiological situation, the NADH dehydrogenase module can attach to the 830 kDa subcomplex to give fully assembled CI, thus NADH dehydrogenase activity. However, this association only occurs when CI is part of a supercomplex containing CIII.
DISCUSSION
In the present study, we performed molecular analysis to determine the nature and penetrance of CI deficiency in different tissues in mice lacking the Ndufs4 gene that lead to a fatal encephalomyopathy. We observed a decrease in spectrophotometric CI activity in all investigated NDUFS4 KO mouse tissues, which is consistent with the fact that CI is ubiquitously expressed and all investigated tissues require NDUFS4 for proper CI function. Nevertheless, significant residual activities were found, explaining the viable phenotype of the KO mice, since complete inactive CI is likely to lead to embryonic lethality. In the original article, describing these mice, no spectrophotometric CI activity was measured in liver, in contrast to our data which exhibit 20% of residual activity in this tissue. This diversity can be explained, as also suggested by the authors, by variances in sample preparation leading to different amounts of functional enzyme due to the CI instability, caused by the absence of NDUFS4 (18) .
Although, the published BN -PAGE analysis showed a decrease in intact CI in brain and liver tissues in KO mice, our high-resolution poly-acrylamide gradient gels show absence of holo-CI (18), and a partially assembled 830 kDa CI subcomplex in the KO mouse tissues. This 830 kDa CI subassembly cannot represent a breakdown product caused by the isolation procedure, because it contains assembly chaperone NDUFAF2, which is absent in the fully assembled CI (15) . Studies on NDUFS4 patient fibroblasts revealed that this 830 kDa subassembly was unable to incorporate radioactive labeled subunits: NDUFS6, NDUFS4 and NDUFV1-V3 (12) . Moreover, this 830 kDa subassembly is also observed in patient fibroblasts with mutations in subunits NDUFS6 and NDUFV1 (15, 21) . These data suggest that the 830 kDa CI subassembly lacks the tip of CI representing the NADH dehydrogenase module. Interestingly, we found a 200 kDa subassembly exclusively in some of the KO tissues. Since this band had NADH oxidation activity and contains at least the subunits NDUFV1 and V2, we deduce that this is likely the NADH dehydrogenase module lacking from the 830 kDa CI subassembly. Although the finding of a separate NADH module has not been reported before, studies show import of radiolabeled NDUFV1 and V2 subunits in mitochondria isolated from NDUFS4 patient fibroblasts into a 200-300 kDa CI subassembly resembling the NADH module we observe here (12) .
There is a discrepancy between the residual enzyme activity measured by the spectrophotometric assays and the lack activity of the 830 kDa subassembly from KO mice. The spectrophotometric assay is based on measuring the rotenonesensitive 2,6-dichloroindophenol reduction by electrons accepted from decylubiquinone. Because the electrons for the oxidation of decylubiquinone come from NADH in this assay, this would not be possible for the 830 kDa subassembly which lacks the NADH dehydrogenase module. In addition, a separate NADH dehydrogenase module would not be able to donate its electrons to decylubiquinone, since it lacks the ubiquinone-binding site. This suggests that binding of the NADH dehydrogenase module to the 830 kDa subassembly is necessary for spectrophotometric activity. Evidence of a loose binding of the NADH dehydrogenase module to the 830 KDa subassembly comes from the investigation of supercomplexes in the muscle tissue. Mild extraction conditions allowed detection of active fully assembled CI in the KO mouse sample, but only in association with CIII. This finding provides evidence that CIII helps CI stabilization. In NDUFS4-deficient patient fibroblasts, the amount of 830 kDa subassembly correlates with the residual CI activity in these cells (22) . Similarly, both the amount of 830 kDa CI subassembly and the amount of 200 kDa subcomplex found in the mouse tissues also crudely correlates with spectrophotometric residual activity observed in the different tissues. This suggests that all of the present 830 and 200 kDa contribute to the formation of an instable but active CI. The instable CI likely leads to an increased degradation resulting in CI deficiency in the investigated tissues.
It was noteworthy that the 830-CIII 2 supercomplex was also observed in WT and Het muscle samples. This suggests that the association of the NADH dehydrogenase module to the 830 kDa subassembly might occur after the formation of an 830 kDa-CIII 2 supercomplex or that the NADH dehydrogenase module was lost after supercomplex formation. The presence of the assembly factor NDUFAF2 in the 830-CIII 2 supercomplex indicates that this supercomplex is likely a physiological entity and not an artifact of the procedure. Interestingly, the presence of tiny amount of NDUFAF2 in CI + CIII 2 supercomplexes might indicate that this assembly factor is released after the addition of the NADH dehydrogenase module. However, more research is needed to understand the precise mechanism of supercomplex formation. The disconnection of the electron input module from the NADH dehydrogenase module might represent a general mechanism of unplugging a possibly crippled complex from its electron influx. Reassembly of this module or exchange of a newly synthesized module might occur as suggested by Lazarou et al. (12) , allowing a restoration of the complex.
Currently, besides supportive care, no cure for mitochondrial CI deficiency exists. Understanding the effects of the single mutations might give clues for therapeutic interventions. In this case, it is clear that NDUFS4 subunit stabilizes the connection between the NADH hydrogenase and rest of the enzyme, which is aided by the formation of supercomplexes. Aside from providing NDUFS4 to the cells, enhancing supercomplex formation or increasing the amount of the NADH dehydrogenase module to further stabilize the complex are possible strategies to ameliorate disease due to CI deficiency.
MATERIALS AND METHODS
Animal experiments
All animal experiments were performed with the approval of the Animal Care and Use Committee of the University of Nijmegen. Previously described mice (18) were fed with a standard animal diet (Ssniff GmbH, Soest, 76. Germany. V1534-300 R/M-H) and water available ad libitum in standard vivarium conditions with 12 h light dark cycle at 228C.
Isolation of mitochondria from mouse tissues
After sacrificing the animals, tissues were prepared and put on ice in mitochondrial isolation buffer [100 mM sucrose, 50 mM KCl, 20 mM TES (pH ¼ 7.2), 1 mM ethylenediaminetetraacetic acid] with 0.2% bovine serum albumin (BSA). The tissues were minced with a Sorvall TC2 tissue chopper, homogenized using a glass/Teflon Potter-Elvehjem homogenizer (1800 rpm in melting ice), in mitochondrial isolation buffer with 0.2% BSA and nagars (1 mg per 1 g of tissue). Next they were centrifuged at 14000g for 10 min at 48C. The resulting supernatant, with floating fat and nagarse, was discarded and the pellet was resuspended in mitochondrial isolation buffer with 0.2% BSA, by hand homogenization. The homogenates were freed from cells debris and nuclei by centrifugation at 600g for 10 min at 48C. The resulting supernatant was centrifuged at 14000g for 10 min at 48C. The pellet was resuspended in mitochondrial isolation buffer with 1 mM mix inhibitor (GE Healthcare), 1 mM phenymethanesulfonyl (Sigma) and re-centrifuged at 14000g for 10 min at 48C. The resulting pellet was resuspended in 100 -200 ml mito-buffer with mix inhibitor and divided in different aliquots of 10 -25 ml each for further analysis and stored at 2808C. The protein amount was measured using micro BCA protein assay kit (Pierce).
Spectrophotometric assay
The CI -CV activities were measured spectrophotometrically in mitochondria isolated from fresh mouse tissues as described (23) .
Blue native PAGE and two-dimensional electrophoresis
Blue native electrophoresis (BN -PAGE), 2D gel electrophoresis, CI in-gel-activity assays and western blotting were performed as previously described (24) .
Supercomplexes analysis
The frozen mitochondria pellet isolated from tissues were solubilized in digitonin by resuspending in 30 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH ¼ 7.4, 150 mM K-acetate, 10% (w/v) glycerol, 1 mM phenylmethanesulfonylfluoride, 1% (w/v) digitonin and incubated on ice for 30 min. The samples were centrifuged for 2 min at 600g. Before loading the sample, buffer (5% Serva G Blue in 750 mM 6 Aminocaproic acid) was added in the ratio of 1:20 to the samples (4, 25) .
Immunodetection and antibodies
Protein immunodetection was performed using the following primary antibodies: NDUFAF2 (B17.2L) (gift from Professor M. Tsuneoka, Kurume, Japan), SDHA, COXVA, alpha-ATPase (Mito Sciences), NDUFS4, NDUFA9, NDUFS3, CORE 2
